Accurate quantitative assessment using gadolinium-contrast magnetic resonance imaging (MRI) is crucial in therapy planning, surveillance and prognostic assessment of primary central nervous system lymphoma (PCNSL). The present study aimed to develop a multimodal artificial intelligence deep learning segmentation model to address the challenges associated with traditional 2D measurements and manual volume assessments in MRI. Data from 49 pathologically-confirmed patients with PCNSL from six Chinese medical centers were analyzed, and regions of interest were manually segmented on contrast-enhanced T1-weighted and T2-weighted MRI scans for each patient, followed by fully automated voxel-wise segmentation of tumor components using a 3-dimenstional convolutional deep neural network. Furthermore, the efficiency of the model was evaluated using practical indicators and its consistency and accuracy was compared with traditional methods. The performance of the models were assessed using the Dice similarity coefficient (DSC). The Mann-Whitney U test was used to compare continuous clinical variables and the χ² test was used for comparisons between categorical clinical variables. T1WI sequences exhibited the optimal performance (training dice: 0.923, testing dice: 0.830, outer validation dice: 0.801), while T2WI showed a relatively poor performance (training dice of 0.761, a testing dice of 0.647, and an outer validation dice of 0.643. In conclusion, the automatic multi-sequences MRI segmentation model for PCNSL in the present study displayed high spatial overlap ratio and similar tumor volume with routine manual segmentation, indicating its significant potential.

Although brain atrophy is a prevalent finding in Wilson disease (WD), its role as a contributing factor to clinical symptoms, especially cognitive decline, remains unclear. The objective of this study was to investigate different neuroimaging biomarkers related to grey matter atrophy and their relationship with neurological and cognitive impairment in WD. In this study, 30 WD patients and 30 age- and sex-matched healthy controls were enrolled prospectively and underwent structural magnetic resonance imaging (MRI). Regional atrophy was evaluated using established linear radiological measurements and the automated workflow volumetric estimation of gross atrophy and brain age longitudinally (veganbagel) for age- and sex-specific estimations of regional brain volume changes. Brain Age Gap Estimate (BrainAGE), defined as the discrepancy between machine learning predicted brain age from structural MRI and chronological age, was assessed using an established model. Atrophy markers and clinical scores were compared between 19 WD patients with a neurological phenotype (neuro-WD), 11 WD patients with a hepatic phenotype (hep-WD), and a healthy control group using Welch's ANOVA or Kruskal-Wallis test. Correlations between atrophy markers and neurological and neuropsychological scores were investigated using Spearman's correlation coefficients. Patients with neuro-WD demonstrated increased third ventricle width and bicaudate index, along with significant striatal-thalamic atrophy patterns that correlated with global cognitive function, mental processing speed, and verbal memory. Median BrainAGE was significantly higher in patients with neuro-WD (8.97 years, interquartile range [IQR] = 5.62-15.73) compared to those with hep-WD (4.72 years, IQR = 0.00-5.48) and healthy controls (0.46 years, IQR = - 4.11-4.24). Striatal-thalamic atrophy and BrainAGE were significantly correlated with neurological symptom severity. Our findings indicate advanced predicted brain age and substantial striatal-thalamic atrophy patterns in patients with neuro-WD, which serve as promising neuroimaging biomarkers for neurological and cognitive functions in treated, chronic WD.

Dynamic glucose enhanced (DGE) MRI studies employ CEST or spin lock (CESL) to study glucose uptake. Currently, these methods are hampered by low effect size and sensitivity to motion. To overcome this, we propose to utilize exchange-based linewidth (LW) broadening of the direct water saturation (DS) curve of the water saturation spectrum (Z-spectrum) during and after glucose infusion (DS-DGE MRI). To estimate the glucose-infusion-induced LW changes (ΔLW), Bloch-McConnell simulations were performed for normoglycemia and hyperglycemia in blood, gray matter (GM), white matter (WM), CSF, and malignant tumor tissue. Whole-brain DS-DGE imaging was implemented at 3 T using dynamic Z-spectral acquisitions (1.2 s per offset frequency, 38 s per spectrum) and assessed on four brain tumor patients using infusion of 35 g of D-glucose. To assess ΔLW, a deep learning-based Lorentzian fitting approach was used on voxel-based DS spectra acquired before, during, and post-infusion. Area-under-the-curve (AUC) images, obtained from the dynamic ΔLW time curves, were compared qualitatively to perfusion-weighted imaging parametric maps. In simulations, ΔLW was 1.3%, 0.30%, 0.29/0.34%, 7.5%, and 13% in arterial blood, venous blood, GM/WM, malignant tumor tissue, and CSF, respectively. In vivo, ΔLW was approximately 1% in GM/WM, 5% to 20% for different tumor types, and 40% in CSF. The resulting DS-DGE AUC maps clearly outlined lesion areas. DS-DGE MRI is highly promising for assessing D-glucose uptake. Initial results in brain tumor patients show high-quality AUC maps of glucose-induced line broadening and DGE-based lesion enhancement similar and/or complementary to perfusion-weighted imaging.

We aimed to compare the diagnostic performance of physicians in the detection of arthroscopically confirmed meniscus and anterior cruciate ligament (ACL) tears on knee magnetic resonance imaging (MRI), with and without assistance from a deep learning (DL) model. We obtained preoperative MR images from 88 knees of patients who underwent arthroscopic meniscal repair, with or without ACL reconstruction. Ninety-eight MR images of knees without signs of meniscus or ACL tears were obtained from a publicly available database after matching on age and ACL status (normal or torn), resulting in a global dataset of 186 MRI examinations. The Keros^® (Incepto, Paris) DL algorithm, previously trained for the detection and characterization of meniscus and ACL tears, was used for MRI assessment. Magnetic resonance images were individually, and blindly annotated by three physicians and the DL algorithm. After three weeks, the three human raters repeated image assessment with model assistance, performed in a different order. The Keros^® algorithm achieved an area under the curve (AUC) of 0.96 (95% CI 0.93, 0.99), 0.91 (95% CI 0.85, 0.96), and 0.99 (95% CI 0.98, 0.997) in the detection of medial meniscus, lateral meniscus and ACL tears, respectively. With model assistance, physicians achieved higher sensitivity (91% vs. 83%, p = 0.04) and similar specificity (91% vs. 87%, p = 0.09) in the detection of medial meniscus tears. Regarding lateral meniscus tears, sensitivity and specificity were similar with/without model assistance. Regarding ACL tears, physicians achieved higher specificity when assisted by the algorithm (70% vs. 51%, p = 0.01) but similar sensitivity with/without model assistance (93% vs. 96%, p = 0.13). The current model consistently helped physicians in the detection of medial meniscus and ACL tears, notably when they were combined. Diagnostic study, Level III.

Given that resection of brainstem cavernous malformations (BSCMs) ends hemorrhaging but carries a high risk of neurological deficits, it is necessary to develop and validate a model predicting surgical outcomes. This study aimed to construct a BSCM surgery outcome prediction model based on clinical characteristics and T2-weighted MRI-based radiomics. Two separate cohorts of patients undergoing BSCM resection were included as discovery and validation sets. Patient characteristics and imaging data were analyzed. An unfavorable outcome was defined as a modified Rankin Scale score > 2 at the 12-month follow-up. Image features were extracted from regions of interest within lesions and adjacent brainstem. A nomogram was constructed using the risk score from the optimal model. The discovery and validation sets comprised 218 and 49 patients, respectively (mean age 40 ± 14 years, 127 females); 63 patients in the discovery set and 35 in the validation set had an unfavorable outcome. The eXtreme Gradient Boosting imaging model with selected radiomics features achieved the best performance (area under the receiver operating characteristic curve [AUC] 0.82). Patients were stratified into high- and low-risk groups based on risk scores computed from this model (optimal cutoff 0.37). The final integrative multimodal prognostic model attained an AUC of 0.90, surpassing both the imaging and clinical models alone. Inclusion of BSCM and brainstem subregion imaging data in machine learning models yielded significant predictive capability for unfavorable postoperative outcomes. The integration of specific clinical features enhanced prediction accuracy.

Medical image registration plays a crucial role in medical imaging, with a wide range of clinical applications. In this context, brain MRI registration is commonly used in clinical practice for accurate diagnosis and treatment planning. In recent years, deep learning-based deformable registration methods have achieved remarkable results. However, existing methods have not been flexible and efficient in handling the feature relationships of anatomical structures at different levels when dealing with large deformations. To address this limitation, we propose a novel strategic integration registration network based on the pyramid structure. Our strategy mainly includes two aspects of integration: fusion of features at different scales, and integration of different neural network structures. Specifically, we design a CNN encoder and a Transformer decoder to efficiently extract and enhance both global and local features. Moreover, to overcome the error accumulation issue inherent in pyramid structures, we introduce progressive optimization iterations at the lowest scale for deformation field generation. This approach more efficiently handles the spatial relationships of images while improving accuracy. We conduct extensive evaluations across multiple brain MRI datasets, and experimental results show that our method outperforms other deep learning-based methods in terms of registration accuracy and robustness.

Osteoarthritis (OA) is heterogeneous and involves structural changes in the whole joint, such as cartilage, meniscus/labrum, ligaments, and tendons, mainly with short T2 relaxation times. Detecting OA before the onset of irreversible changes is crucial for early proactive management and limit growing disease burden. The more recent advanced quantitative imaging techniques and deep learning (DL) algorithms in musculoskeletal imaging have shown great potential for visualizing "pre-OA." In this review, we first focus on ultrashort echo time-based magnetic resonance imaging (MRI) techniques for direct visualization as well as quantitative morphological and compositional assessment of both short- and long-T2 musculoskeletal tissues, and second explore how DL revolutionize the way of MRI analysis (eg, automatic tissue segmentation and extraction of quantitative image biomarkers) and the classification, prediction, and management of OA. PLAIN LANGUAGE SUMMARY: Detecting osteoarthritis (OA) before the onset of irreversible changes is crucial for early proactive management. OA is heterogeneous and involves structural changes in the whole joint, such as cartilage, meniscus/labrum, ligaments, and tendons, mainly with short T2 relaxation times. Ultrashort echo time-based magnetic resonance imaging (MRI), in particular, enables direct visualization and quantitative compositional assessment of short-T2 tissues. Deep learning is revolutionizing the way of MRI analysis (eg, automatic tissue segmentation and extraction of quantitative image biomarkers) and the detection, classification, and prediction of disease. They together have made further advances toward identification of imaging biomarkers/features for pre-OA. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY: Stage 2.

Mild traumatic brain injury (mTBI) caused by sports-related incidents in children and youth often leads to prolonged cognitive impairments but remains difficult to diagnose. In order to identify clinically relevant imaging and behavioral biomarkers associated concussion, a closed-head mTBI was induced in adolescent pigs. Twelve (n = 4 male and n = 8 female), 16-week old Yucatan pigs were tested; n = 6 received mTBI and n = 6 received a sham procedure. T1-weighted imaging was used to assess volumetric alterations in different regions of the brain and diffusion tensor imaging (DTI) to examine microstructural damage in white matter. The pigs were imaged at 1- and 3-month post-injury. Neuropsychological screening for executive function and anxiety were performed before and in the months after the injury. The volumetric analysis showed significant longitudinal changes in pigs with mTBI compared with sham, which may be attributed to swelling and neuroinflammation. Fractional anisotropy (FA) values derived from DTI images demonstrated a 21% increase in corpus callosum from 1 to 3 months in mTBI pigs, which is significantly higher than in sham pigs (4.8%). Additionally, comparisons of the left and right internal capsules revealed a decrease in FA in the right internal capsule for mTBI pigs, which may indicate demyelination. The neuroimaging results suggest that the injury had disrupted the maturation of white and gray matter in the developing brain. Behavioral testing showed that compare to sham pigs, mTBI pigs exhibited 23% increased activity in open field tests, 35% incraesed escape attempts, along with a 65% decrease in interaction with the novel object, suggesting possible memory impairments and cognitive deficits. The correlation analysis showed an associations between volumetric features and behavioral metrics. Furthermore, a machine learning model, which integrated FA, volumetric features and behavioral test metrics, achieved 67% accuracy, indicating its potential to differentiate the two groups. Thus, the imaging biomarkers were indicative of long-term behavioral impairments and could be crucial to the clinical management of concussion in youth.

Meningiomas are among the most common intracranial tumors, and challenges still remain in terms of tumor classification, treatment, and management. With the popularization of artificial intelligence technology, radiomics has been further developed and more extensively applied in the study of meningiomas. This objective and quantitative technique has played an important role in the identification, classification, grading, pathology, treatment, and prognosis of meningiomas, although new problems have also emerged. This review examines the application of magnetic resonance imaging (MRI) techniques in meningioma research. A database search was conducted for articles published between November 2017 and April 2025, with a total of 87 studies included after screening. These studies were summarized in detail, and the risk of bias and the certainty of the evidence were assessed using the Quality Assessment of Diagnostic Accuracy Studies version 2 (QUADAS-2) and radiomics quality scores (RQS). All the studies were retrospective, with most being single-center studies. Contrast-enhanced T1-weighted imaging (T1C) and T2-weighted imaging (T2WI) are the most commonly used MRI sequences. Current research focuses on five topics, namely, differentiation, grade and subtypes, molecular pathology, biological behavior, treatment, and complications, with 14, 32, 14, 12, and 19 studies addressing these topics (some of which are multiple topics). Combined imaging features with clinical or pathological features often outperform traditional clinical models. Most studies show a low to moderate risk of bias. Large, prospective, multicenter studies are needed to validate the performance of radiomic models in diverse patient populations before their clinical implementation can be considered.

Diagnosing Parkinson's disease (PD) typically relies on clinical evaluations, often detecting it in advanced stages. Recently, artificial intelligence has increasingly been applied to imaging for neurodegenerative disorders. This study aims to develop a diagnostic prediction model using T1-weighted magnetic resonance imaging (T1-MRI) data from the caudate and putamen in individuals with early-stage PD. This retrospective case-control study included 69 early-stage PD patients and 22 controls, recruited through the Parkinson's Progression Markers Initiative. T1-MRI scans were acquired using a 3-tesla system. 432 radiomic features were extracted from images of the segmented caudate and putâmen in an automated way. Feature selection was performed using Pearson's correlation and recursive feature elimination to identify the most relevant variables. Three machine learning algorithms-random forest (RF), support vector machine and logistic regression-were evaluated for diagnostic prediction effectiveness using a cross-validation method. The Shapley Additive Explanations technique identified the most significant features distinguishing between the groups. The metrics used to evaluate the performance were discrimination, expressed in area under the ROC curve (AUC), sensitivity and specificity; and calibration, expressed as accuracy. The RF algorithm showed superior performance with an average accuracy of 92.85%, precision of 100.00%, sensitivity of 86.66%, specificity of 96.65% and AUC of 0.93. The three most influential features were contrast, elongation, and gray-level non-uniformity, all from the putamen. Machine learning-based models can differentiate early-stage PD from controls using T1-weighted MRI radiomic features.